文献速递妇科

组织因子作为超声微泡早期检测卵巢癌的新型诊断靶点

Tissue factor as a novel diagnostic target for early detection of ovarian cancer using ultrasound microbubbles.
PubMed 文献 · Gynecol Oncol · 2023-05-11

本研究针对卵巢癌(OC)现有检测标志物CA125和超声特异性不足的问题,探索以组织因子(TF)为靶点的超声微泡。在OC细胞系、患者来源肿瘤样本及高级别浆液性卵巢癌原位小鼠模型中验证TF表达与微泡结合。结果显示TF在鼠源和人源卵巢肿瘤相关血管内皮细胞(VEC)表达,TF靶向微泡可成功结合TF表达OC细胞及肿瘤相关VEC。

要点

  • TF表达于鼠源和人源卵巢肿瘤相关血管内皮细胞。
  • TF靶向微泡可结合TF表达OC细胞及血管生成内皮体外模型。
  • TF靶向微泡在原位OC小鼠模型中结合肿瘤相关VEC。

核心结论

  • 开发能成功检测卵巢肿瘤新生血管的TF靶向微泡,可能对增加早期OC诊断数量有重要意义。
  • 这项临床前研究显示有转化为临床应用的潜力,最终可能帮助增加早期OC检出并降低该病相关死亡率。

研究设计与样本

  • 临床前研究,采用OC细胞系、患者来源肿瘤样本及高级别浆液性卵巢癌原位小鼠模型。
  • 通过蛋白质印迹和免疫组化检测TF表达,并进行体外结合实验及体内微泡超声成像分析。

主要发现

  • TF表达见于鼠源和人源卵巢肿瘤相关血管内皮细胞。
  • 生物素化抗TF抗体偶联至链霉亲和素包被微泡后,TF靶向微泡成功结合TF表达OC细胞及血管生成内皮体外模型。
  • 在体内,TF靶向微泡结合临床相关原位OC小鼠模型的肿瘤相关血管内皮细胞。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Ovarian cancer (OC) is the deadliest gynecologic malignancy, with an overall 5-year survival rate of less than 30%. The existing paradigm for OC detection involves a serum marker, CA125, and ultrasound examination, neither of which is sufficiently specific for OC. This study addresses this deficiency through the use of a targeted ultrasound microbubble directed against tissue factor (TF). METHODS: TF expression was examined in both OC cell lines and patient-derived tumor samples via western blotting and IHC. In vivo microbubble ultrasound imaging was analyzed using high grade serous ovarian carcinoma orthotopic mouse models. RESULTS: While TF expression has previously been described on angiogenic, tumor-associated vascular endothelial cells (VECs) of several tumor types, this is first study to show TF expression on both murine and patient-derived ovarian tumor-associated VECs. Biotinylated anti-TF antibody was conjugated to streptavidin-coated microbubbles and in vitro binding assays were performed to assess the binding efficacy of these agents. TF-targeted microbubbles successfully bound to TF-expressing OC cells, as well as an in vitro model of angiogenic endothelium. In vivo, these microbubbles bound to the tumor-associated VECs of a clinically relevant orthotopic OC mouse model. CONCLUSION: Development of a TF-targeted microbubble capable of successfully detecting ovarian tumor neovasculature could have significant implications towards increasing the number of early-stage OC diagnoses. This preclinical study shows potential for translation to clinical use, which could ultimately help increase the number of early OC detections and decrease the mortality associated with this disease.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Newcomer MM, Dorayappan KDP, Wagner V, et al. Tissue factor as a novel diagnostic target for early detection of ovarian cancer using ultrasound microbubbles. Gynecol Oncol. 2023. PMID: 37178671. doi:10.1016/j.ygyno.2023.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。